Dr. Chung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Fruit Street Blk 4
Gastroenterology Associates
Boston, MA 02114Phone+1 617-724-6006Fax+1 617-724-6832- Is this information wrong?
Summary
- Dr. Raymond Chung is a gastroenterologist and hepatologist in Boston, MA and is Chief of Hepatology at Massachusetts General Hospital. He received his medical degree from Yale School of Medicine and has been in practice 31 years. He specializes in hepatology & liver transplantation and is experienced in hepatology.
Education & Training
- Massachusetts General HospitalFellowship, Gastroenterology, 1989 - 1993
- Johns Hopkins UniversityResidency, Internal Medicine, 1986 - 1989
- Yale School of MedicineClass of 1986
Certifications & Licensure
- MA State Medical License 1989 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2008, 2012-2014
Clinical Trials
- A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV) Start of enrollment: 2000 Nov 01
- Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) Start of enrollment: 2004 Jul 01
- Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus Start of enrollment: 2006 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- The Edmonton Symptom Assessment System is a valid, reliable, and responsive tool to assess symptom burden in decompensated cirrhosis.John Donlan, Chengbo Zeng, Teresa Indriolo, Lucinda Li, Enya Zhu, Kedie Pintro, Nora Horick, Maria Edelen, Joyce Zhou, Raymond T Chung, Areej El-Jawahri, Nneka N Ufere> ;Hepatology Communications. 2024 Apr 1
- New window into hepatitis B in Africa: Liver sampling combined with single cell omics enables deep and longitudinal assessment of intrahepatic immunity in Zambia.Musonda, T., Wallace, M., Patel, H., Martin, O., Oetheimer, C., Mwakamui, S., Sinkala, E., Nsokolo, B., Kanunga, A., Lauer, G., Wandeler, G., Kelly, P., Alatrakchi, N....> ;The Journal of Infectious Diseases. 2024 Feb 9
- HBV reactivation and clinical resolution in an isolated anti-HBc-positive patient during immune checkpoint inhibition.Baumert, L., Shih, A., Chung, R.> ;Med. 2024 Feb 9
- Join now to see all
Journal Articles
- Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-Infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort StudyMandana Khalili, Mark Sulkowski, Marc G Ghany, Richard K Sterling, Raymond T Chung, David E Kleiner, Mamta K Jain, Nature
- A Novel lncRNA Regulates HCV Infection Through IFI6Raymond T Chung, Esperance A Schaefer, Hepatology
- Serum Angiopoietin‐2 Predicts Mortality and Kidney Outcomes in Decompensated CirrhosisAndrew S Allegretti, Sagar U Nigwekar, Raymond T Chung, Sahir Kalim, Xavier Vela Parada, Ravi I Thadhani, Guillermo A Ortiz, Samir M Parikh, Hepatology
- Join now to see all
Other
- Investigational therapies for hepatitis C virus infectionChung RT, Tai AW
http://www.uptodate.com/contents/investigational-therapies-for-hepatitis-c-virus-infection
UpToDate, Wolters Kluwer Health - 2013-04-05 - Studies of telaprevir and boceprevir in the treatment of chronic hepatitis C virus genotype 1Chung RT, Tai AW
http://www.uptodate.com/contents/studies-of-telaprevir-and-boceprevir-in-the-treatment-of-chronic-he
UpToDate, Wolters Kluwer Health - 2012-10-05
Authored Content
- The Nonalcoholic Fatty Liver Disease (NAFLD) Fibrosis Score, Cardiovascular Risk Stratification and a Strategy for Secondary Prevention with EzetimibeMay 2018
Grant Support
- Discovery And Assessment Of Genetic Determinants Of HCV And HIV ControlNational Institute On Drug Abuse2011
- Research Training In Digestive DiseasesNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- The Central Role Of The Hepatocyte In HCV PersistenceNational Institute Of Allergy And Infectious Diseases2009–2011
- Pilot/Feasibility Studies Program Of The HCV Persistence Study Group (HPSG)National Institute Of Allergy And Infectious Diseases2009–2011
- Mechanisms Of Immune Failure In Chronic Infection: Hepatitis C As A Key ParadigmNational Institute Of Allergy And Infectious Diseases2009–2011
- Administrative Core For The HCV Persistence Study Group (HPSG)National Institute Of Allergy And Infectious Diseases2009–2011
- Harvard Hepatitis B ConsortiumNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Patient-Oriented Research On Hepatitis In Special PopulationsNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
- Discovery And Assessment Of Genetic Determinants Of HCV And HIV ControlNational Institute Of Allergy And Infectious Diseases2010
- Serum Apoptosis Markers As Biomarkers In Acute Liver FailureNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Hiv-Hepatitis C Virus Interactions And PathogenesisNational Institute Of Allergy And Infectious Diseases2006–2010
- Chemical Genetics:Cellular Regulators Of HCV (RMI)National Institute Of Neurological Disorders And Stroke2004
- Novel Animal Models Of Hcv-Related HepatocarcinogenesisNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
- Hepatitis C Virus-Specific ReplicaseNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1998
Hospital Affiliations
- Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: